Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Terns Pharmaceuticals Announced Topline Data From Its Phase 1 Trial Of TERN-601 Dosed Once-daily In Healthy Adults With Obesity Or Overweight, Showed A Statistically Significant Mean Weight Loss Up To 5.5% Over 28 Days

Author: Benzinga Newsdesk | September 09, 2024 07:07am

Posted In: TERN